(EXPRESS) — TWO patients suffering from the most common form of sight loss in the UK have successfully regained their reading vision after a groundbreaking clinical study.
A man in his early 80s and a woman in her early 60s received a new stem cell-based treatment for age-related macular degeneration (AMD), a condition which leads to a rapid loss of central vision.
It is the first time an engineered piece of tissue has been successfully used to treat people with sudden severe sight loss.
